Rankings
▼
Calendar
ZVRA Q1 2019 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ZVRA
Zevra Therapeutics, Inc.
$559M
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$11M
Net Income
-$12M
EPS (Diluted)
$-7.36
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$20M
Total Liabilities
$95M
Stockholders' Equity
-$75M
Cash & Equivalents
$13M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$11M
-$15M
+23.0%
Net Income
-$12M
-$26M
+53.1%
← FY 2019
All Quarters
Q2 2019 →